Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma

International Archives of Allergy and Immunology

Volumn 109, Issue 3, 1996, Pages 272-276

  Fasce, Lilia ^a   Ciprandi, Giorgio ^b   Pronzato, Caterina ^b   Cozzani, Simonetta ^a   Tosca, Maria Angela ^b   Grimaldi, Ivana ^c   Canonica, Giorgio Walter ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UCB Laboratories   (Italy)

Author keywords

Adhesion molecules; Allergic inflammation; Cetirizine; Children; Mite allergy

Indexed keywords

ALLERGEN; CETIRIZINE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; EPITHELIUM CELL; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MITE; NEUTROPHIL; NOSE MUCOSA; ORAL DRUG ADMINISTRATION; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; RELAPSE; RHINITIS; RHINOVIRUS; VIRUS INFECTION;

EID: 0030022353     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237249     Document Type: Article

References (15)

1. Djukanovich R. Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH. Holgate ST: Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
2. IL-8 is a potent eosinophil chemoattractant editorial. Clin Exp Allergy 1994:24:203-206.
3. Ciprandi G, Buscaglia S, Pesce GP, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW: Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitis patients with allergy due to mites. J Allergy Clin Immunol, in press.
4. Ciprandi G, Buscaglia S, Pcscc GP, Villaggio B, Bagnasco M, Canonica GW: Allergic subjects express intercellular adhesion molecules-1 (ICAM-I or C'D54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993;91:783-792.
5. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW: Evidence of ICAM-I expression on nasal epithelial cells in acute rhinoconjunctivitis due to pollen exposure. J Allergy Clin Immunol 1994;99:738-746
6. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW: Allergen-specific challenge induces intercellular adhesion molecule-1 (ICAM-I or CD54) on nasal epithelial cells in allergic subjects: Relationships with early and late inflammatory phenomena. Am J Respir Crit Care Med 1994; 150:1653-1659.
7. Ciprandi G. Buscaglia S. Pesce GP. Bagnasco M. Canonica GW: 1CAM-1/CD54 expression on conjunctival epithelium during pollen season. Allergy 1995;50:184-187.
8. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma. Am Rev Respir Dis 1989; 140:1745-1753.
9. Spencer CM, Faulds D, Peters D: Cetirizine: A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993:46:1055-1080.
10. Ciprandi G, Buscaglia S, Pesce GP, Passalacqua G. Rihoux JP, Bagnasco M, Canonica GW: Cetirizine reduces ICAM-I (or CD54) expression both in early and late phase events following allergen-specific conjunctival challenge. J Allergy Clin Immunol 1995:95:612-621.
11. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, McDonald S, Pulford KAF, Stein H, Mason DY: Immunocnzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAAP complexes) J Histochem Cytochem 1984;32:219-245.
12. Ciprandi G, Buscaglia S, Pesce GP, Bagnasco M, Canonica GW: Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis. J Allergy Clin Immunol 1993:91:1227-1230.
13. Ciprandi G, Buscaglia S. Pesce GP. Lotti R, Rolando M. Bagnasco M. Canonica GW: Effects of conjunctival hyperosmolar challenge in allergic subjects and normal controls. Int Arch Allergy Immunol 1994:104:92-96.
14. Pattemore OK, Johnston SL, Bardin PG: Viruses as précipitants of asthma symptoms. I: Epidemiology. Clin Exp Allergy 1992:22:325-336.
15. Ciprandi G, Buscaglia S, Pesce GP, Iudice A, Bagnasco M, Canonica GW: Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test. Allergy 1993:48: 421-430.